Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab vs . Sunitinib) for Advanced Renal Cell Carcinoma
Anticancer Research · 2026-07 · 46 (7) · 3889-3896
DOI: 10.21873/anticanres.18250 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Anticancer Research, online erschienen am 29.06.2026. Verfasst von Motohiro Fujiwara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Teikyo University Hospital, Mizonokuchi, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Kidney Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Teikyo University Hospital, Mizonokuchi, Japan.
- Department of Urology, Institute of Science Tokyo, Tokyo, Japan; s-yoshida.uro@tmd.ac.jp.
- Department of Urology, National Cancer Center Hospital East, Chiba, Japan.
- Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
- Department of Urology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
Zitieren
APA
Fujiwara, M., Yoshida, S., Yajima, S., Sato, H., Hirakawa, A., Fukushima, H., Arita, Y., Tanaka, H., Yokoyama, M., Masuda, H., & Fujii, Y. (2026). Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab vs . Sunitinib) for Advanced Renal Cell Carcinoma. Anticancer Research, 46(7), 3889-3896. https://doi.org/10.21873/anticanres.18250
Vancouver
Fujiwara M, Yoshida S, Yajima S, Sato H, Hirakawa A, Fukushima H, et al. Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab vs . Sunitinib) for Advanced Renal Cell Carcinoma. Anticancer Research. 2026;46(7):3889-3896. doi:10.21873/anticanres.18250
BibTeX
@article{Fujiwara2026,
author = {Fujiwara, Motohiro and Yoshida, Soichiro and Yajima, Shugo and Sato, Hiroyuki and Hirakawa, Akihiro and Fukushima, Hiroshi and Arita, Yuki and Tanaka, Hajime and Yokoyama, Minato and Masuda, Hitoshi and Fujii, Yasuhisa},
title = {Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab vs . Sunitinib) for Advanced Renal Cell Carcinoma},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {7},
pages = {3889--3896},
doi = {10.21873/anticanres.18250}
}
EUVIMED